Boston Scientific (BSX) is at a critical technical juncture after a significant decline, testing support levels not seen in over a year. The stock has fallen nearly 33% from its peak, and its ability to hold above $71.88 will determine if it can experience a relief bounce or face further selling pressure. Traders are advised to monitor these key support levels closely for potential entry or continuation signals.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Boston Scientific tests make-or-break support after steep decline
Boston Scientific (BSX) is at a critical technical juncture after a significant decline, testing support levels not seen in over a year. The stock has fallen nearly 33% from its peak, and its ability to hold above $71.88 will determine if it can experience a relief bounce or face further selling pressure. Traders are advised to monitor these key support levels closely for potential entry or continuation signals.